The Canadian Bioceutical CBICF

Quarterly earnings expectations

[Bmclav]

What are everyone’s expectations for MPX’s quarterly release on the 29th?


I’m conservatively expecting quarterly revenue of $16  million, double the 8 million from last quarter.

They’ve been earning $5 mill/month ever since March solely from Arizona operations, and that number is likely higher now as they’ve added a 4th dispensary.

Nevada sales have begun early 2018 from my understanding, however I’m estimating they only contributed a couple mill throughout the quarter.

I believe that’s the bulk of their revenues for now, however Massachusetts, Maryland, and Cali will all start contributing revenue very soon (I believe Massachusetts opened a dispensary in Aug).

This release should also see us move up to top 3-4 in revenue for cannabis companies (same ballpark as Aphria)

The one true unknown for me right now is MPX’s Canadian operations, as we still haven’t received our license from health Canada and that’s a bit concerning. I liked the Canveda acquisition but shouldn’t we have received our license by now? Does anyone have any recent information on this ?

Anyways, trying to temper expectations but I still expect a 100% jump in revenues QoQ Just based on their news release of $5 mill/month back in March.

Long $MPX

Cheers